FDA Eli Lilly - Search News

Eli Lilly announces $27-billion US expansion

CNN on MSN · 6h

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

Hosted on MSN · 3h

Eli Lilly will build 4 new manufacturing sites to increase domestic drug production

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants later this year.

Eli Lilly announces $27 billion investment in U.S. drug manufacturing sites

Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is seeking to press drugmakers to move stateside.

2hon MSN

Eli Lilly to Build 4 New Factories. Why That’s More Important Than the Cost.

Eli Lilly is building four new manufacturing sites, the drug company announced Wednesday, and though the $27 billion price ...

5h

InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

1don MSN

Eli Lilly to Offer Higher Doses of Obesity Drug Zepbound at Discounted Prices

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

9hon MSN

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results